Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |